TMDX - TransMedics Group, Inc.

90.19
-3.310   -3.670%

Share volume: 1,127,525
Last Updated: 04-28-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 1.01%

PREVIOUS CLOSE
CHG
CHG%
$93.50
-3.31
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
37%
Profitability 25%
Dept financing 21%
Liquidity 65%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.24%
1 Month
34.05%
3 Months
37.63%
6 Months
1.91%
1 Year
-7.26%
2 Year
15.85%
Key data
Stock price
$90.19
P/E Ratio 
59.01
DAY RANGE
$88.50 - $95.70
EPS 
-$1.01
52 WEEK RANGE
$55.00 - $177.37
52 WEEK CHANGE
-$4.19
MARKET CAP 
2.093 B
YIELD 
N/A
SHARES OUTSTANDING 
33.359 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
1.06
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,102,651
AVERAGE 30 VOLUME 
$1,214,318
Company detail
CEO: Waleed H. Hassanein
Region: US
Website: transmedics.com
Employees: 210
IPO year: 2019
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

TransMedics Group, Inc. engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation.

Recent news
loading